|
| James E Udelson | Stony Brook University, Tufts Medical Center, Inova Heart & Vascular Institute, Henry Ford Hospital, University of Brescia and Civil Hospital, Northwestern University Feinberg School of Medicine, Wake Forest School of Medicine, University of California San Francisco (J.R.T.) Merck & Co., C.S.) Amgen Inc., HELIOS Clinic Wuppertal, University Hospital Witten/Herdecke, L.-M.G.) Relypsa Inc., M.M.) Vifor Pharma, Nippon Medical School Musashi-Kosugi Hospital, Japan (S.I.) Novartis Pharmaceuticals Inc., V.S.) Sanford Burnham Prebys Medical Discovery Institute, CA (C.J.L.) Bayer Pharma AG, Columbia University Medical Center, NY (C.R.) Boehringer Ingelheim Pharmaceuticals Inc, MD (N.S.) Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University |
| John R Teerlink | Stony Brook University, Tufts Medical Center, Inova Heart & Vascular Institute, Henry Ford Hospital, University of Brescia and Civil Hospital, Northwestern University Feinberg School of Medicine, Wake Forest School of Medicine, University of California San Francisco (J.R.T.) Merck & Co., C.S.) Amgen Inc., HELIOS Clinic Wuppertal, University Hospital Witten/Herdecke, L.-M.G.) Relypsa Inc., M.M.) Vifor Pharma, Nippon Medical School Musashi-Kosugi Hospital, Japan (S.I.) Novartis Pharmaceuticals Inc., V.S.) Sanford Burnham Prebys Medical Discovery Institute, CA (C.J.L.) Bayer Pharma AG, Columbia University Medical Center, NY (C.R.) Boehringer Ingelheim Pharmaceuticals Inc, MD (N.S.) Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University |
| Norman Stockbridge | Stony Brook University, Tufts Medical Center, Inova Heart & Vascular Institute, Henry Ford Hospital, University of Brescia and Civil Hospital, Northwestern University Feinberg School of Medicine, Wake Forest School of Medicine, University of California San Francisco (J.R.T.) Merck & Co., C.S.) Amgen Inc., HELIOS Clinic Wuppertal, University Hospital Witten/Herdecke, L.-M.G.) Relypsa Inc., M.M.) Vifor Pharma, Nippon Medical School Musashi-Kosugi Hospital, Japan (S.I.) Novartis Pharmaceuticals Inc., V.S.) Sanford Burnham Prebys Medical Discovery Institute, CA (C.J.L.) Bayer Pharma AG, Columbia University Medical Center, NY (C.R.) Boehringer Ingelheim Pharmaceuticals Inc, MD (N.S.) Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University |
| Mihai Gheorghiade | Stony Brook University, Tufts Medical Center, Inova Heart & Vascular Institute, Henry Ford Hospital, University of Brescia and Civil Hospital, Northwestern University Feinberg School of Medicine, Wake Forest School of Medicine, University of California San Francisco (J.R.T.) Merck & Co., C.S.) Amgen Inc., HELIOS Clinic Wuppertal, University Hospital Witten/Herdecke, L.-M.G.) Relypsa Inc., M.M.) Vifor Pharma, Nippon Medical School Musashi-Kosugi Hospital, Japan (S.I.) Novartis Pharmaceuticals Inc., V.S.) Sanford Burnham Prebys Medical Discovery Institute, CA (C.J.L.) Bayer Pharma AG, Columbia University Medical Center, NY (C.R.) Boehringer Ingelheim Pharmaceuticals Inc, MD (N.S.) Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University |